4.6 Article

Lobectomy Is Associated with Better Outcomes than Sublobar Resection in Spread through Air Spaces (STAS)-Positive T1 Lung Adenocarcinoma: A Propensity Score-Matched Analysis

Journal

JOURNAL OF THORACIC ONCOLOGY
Volume 14, Issue 1, Pages 87-98

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jtho.2018.09.005

Keywords

Lung adenocarcinoma; Wedge resection; Recurrence; Lobectomy

Funding

  1. National Institutes of Health [R01 CA236615, R01 217169, P30 CA008748]
  2. U.S. Department of Defense [LC160212, CA170630, BC132124]
  3. Joanne and John DallePezze Foundation
  4. Derfner Foundation
  5. Commonwealth Foundation for Cancer Research
  6. Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center

Ask authors/readers for more resources

Introduction: Spread through air spaces (STAS) is a form of invasion wherein tumor cells extend beyond the tumor edge within the lung parenchyma. In lung adenocarcinoma (ADC), we investigated the (1) association between STAS and procedure-specific outcomes (sublobar resection and lobectomy), (2) effect of surgical margin-to-tumor diameter ratio in STAS-positive patients, and (3) potential utility of frozen sections (FSs) for detecting STAS intraoperatively. Methods: We investigated 1497 patients who underwent lobectomy (n = 970) or sublobar resection (n = 527) for T1N0M0 lung ADC after propensity score matching. Outcomes were analyzed by using a competing risks approach. The effect of margin-to-tumor ratio on recurrence pattern (locoregional and distant) was investigated in patients who underwent sublobar resection. Five pathologists evaluated the feasibility of intraoperatively identifying STAS by using FSs (sensitivity, specificity, and interrater reliability). Results: On multivariable analysis after propensity score matching (349 pairs/procedure), sublobar resection was significantly associated with recurrence (subhazard ratio = 2.84 [p < 0.001]) and lung cancer-specific death (subhazard ratio = 2.63 [p = 0.021]) in patients with STAS but not in those without STAS. Patients with STAS who underwent sublobar resection had a higher risk of locoregional recurrence regardless of margin-to-tumor ratio (for a margin-to-tumor ratio of >= 1 versus < 1, the 5-year cumulative incidence of recurrence rates were 16% and 25%, respectively); among patients without STAS, locoregional recurrences occurred in patients with margin-to-tumor ratio lower than 1 (a 5-year cumulative incidence of recurrence rate of 7%). The sensitivity and specificity for detecting STAS by use of FSs were 71% and 92%, with substantial interrater reliability (Gwet's AC1, 0.67). Conclusions: In patients with T1 lung ADC with STAS, lobectomy was associated with better outcomes than sublobar resection was. Pathologists can recognize STAS on FSs. (C) 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Cardiac & Cardiovascular Systems

Performance Comparison Between SURPAS and ACS NSQIP Surgical Risk Calculator in Pulmonary Resection

Neel P. Chudgar, Shi Yan, Meier Hsu, Kay See Tan, Katherine D. Gray, Daniela Molena, Tamar Nobel, Prasad S. Adusumilli, Manjit Bains, Robert J. Downey, James Huang, Bernard J. Park, Gaetano Rocco, Valerie W. Rusch, Smita Sihag, David R. Jones, James M. Isbell

Summary: The study compared the observed and predicted outcomes after pulmonary resections between SURPAS and NSQIP SRC. Results showed no significant differences in discrimination performance between the two models for most complications, except for renal failure. The NSQIP SRC performed better in discriminating the risk of renal failure compared to SURPAS.

ANNALS OF THORACIC SURGERY (2021)

Article Cardiac & Cardiovascular Systems

Thoracic Metastasectomy in Germ Cell Tumor Patients Treated With First-line Versus Salvage Therapy

Raul Caso, Gregory D. Jones, Kay See Tan, George J. Bosl, Samuel A. Funt, Joel Sheinfeld, Victor E. Reuter, David Amar, Gregory Fischer, Daniela Molena, Gaetano Rocco, Manjit S. Bains, Darren R. Feldman, David R. Jones

Summary: This study explored the outcomes of thoracic metastasectomy in GCT patients who received first-line chemotherapy alone versus salvage chemotherapy. Patients treated with salvage chemotherapy had more aggressive disease and worse PFS, but achieved encouraging OS. Aggressive thoracic metastasectomy plays an integral role in treating GCT patients with residual thoracic disease after chemotherapy.

ANNALS OF THORACIC SURGERY (2021)

Article Cardiac & Cardiovascular Systems

Three-dimensional computed tomography and indocyanine green-guided technique for pulmonary sequestration surgery

Shunichiro Matsuoka, Takashi Eguchi, Tetsu Takeda, Kentaro Miura, Kazutoshi Hamanaka, Kimihiro Shimizu

Summary: Using a combination of 3D-CT imaging and ICG fluorescence navigation, lung resection in patients with pulmonary sequestration can safely and effectively identify and divide aberrant arteries, draining veins, and resection margins intraoperatively.

GENERAL THORACIC AND CARDIOVASCULAR SURGERY (2021)

Article Cardiac & Cardiovascular Systems

The American College of Surgeons Surgical Risk Calculator performs well for pulmonary resection: A validation study

Neel Chudgar, Shi Yan, Meier Hsu, Kay See Tan, Katherine D. Gray, Daniela Molena, David R. Jones, Valerie W. Rusch, Gaetano Rocco, James M. Isbell

Summary: The NSQIP SRC can reasonably predict postoperative complications in patients undergoing pulmonary resection, except for certain calibration issues.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2022)

Article Surgery

A Genomic-Pathologic Annotated Risk Model to Predict Recurrence in Early-Stage Lung Adenocarcinoma

Gregory D. Jones, Whitney S. Brandt, Ronglai Shen, Francisco Sanchez-Vega, Kay See Tan, Axel Martin, Jian Zhou, Michael Berger, David B. Solit, Nikolaus Schultz, Hira Rizvi, Yuan Liu, Ariana Adamski, Jamie E. Chaft, Gregory J. Riely, Gaetano Rocco, Matthew J. Bott, Daniela Molena, Marc Ladanyi, William D. Travis, Natasha Rekhtman, Bernard J. Park, Prasad S. Adusumilli, David Lyden, Marcin Imielinski, Marty W. Mayo, Bob T. Li, David R. Jones

Summary: The integration of genomic and clinicopathologic features can better predict recurrence in early-stage LUAD patients after surgical resection, potentially enhancing accrual to clinical trials.

JAMA SURGERY (2021)

Article Cardiac & Cardiovascular Systems

Predictors of survival following surgical resection of limited-stage small cell lung cancer

Nicolas Zhou, Matthew Bott, Bernard J. Park, Eric Vallieres, Candice L. Wilshire, Kazuhiro Yasufuku, Jonathan D. Spicer, David R. Jones, Boris Sepesi

Summary: The study highlights the survival benefit of adjuvant chemotherapy in limited-stage SCLC, but did not find a statistically significant influence from mediastinal PORT or PCI in the cohort. Larger prospective studies are needed to determine the benefits of PORT or PCI in a surgically resected limited-stage SCLC population.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2021)

Editorial Material Cardiac & Cardiovascular Systems

Thymic Malignancy Still Needs Aggressive Surgery: Safety and Oncologic Feasibility of Superior Vena Cava Resection

Takashi Eguchi, Kazutoshi Hamanaka, Kimihiro Shimizu

ANNALS OF THORACIC SURGERY (2021)

Article Pathology

Usefulness of SS18-SSX antibody as a diagnostic marker for pulmonary metastatic synovial sarcoma

Kentaro Miura, Kimihiro Shimizu, Takashi Eguchi, Sachie Koike, Shunichiro Matsuoka, Tetsu Takeda, Kazutoshi Hamanaka, Takeshi Uehara

Summary: The study demonstrated the high sensitivity and specificity of SS18-SSX antibody in diagnosing pulmonary metastatic SS. The positive results in 100% of metastatic SS cases and 0% of clinical and histologic mimics suggest its potential application in clinical practice. This simple and reliable immunohistochemistry method may serve as a substitute for traditional genomic tests.

DIAGNOSTIC PATHOLOGY (2021)

Review Oncology

Technical Advances in Segmentectomy for Lung Cancer: A Minimally Invasive Strategy for Deep, Small, and Impalpable Tumors

Takashi Eguchi, Toshihiko Sato, Kimihiro Shimizu

Summary: By discussing and summarizing key issues related to minimally invasive segmentectomy, including preoperative planning and intraoperative tumor localization, we can help overcome the technical challenges associated with this procedure.

CANCERS (2021)

Article Cardiac & Cardiovascular Systems

Prediction of Pulmonary Artery-Adherent Lymph Nodes for Minimally Invasive Lung Resection

Tetsu Takeda, Shunichiro Matsuoka, Kentaro Miura, Kazutoshi Hamanaka, Kimihiro Shimizu, Takashi Eguchi

Summary: This study investigated predictors of PA-adherent lymph nodes and conversion/PA injury during minimally invasive surgery. Bronchoscopy and CT were found to be independent predictors, with the combination of dark pigmentation and LN size useful in stratifying patients' risk of PA-adherent LNs. The presence of PA-adherent LNs was associated with a higher risk of conversion and PA injury during MIS.

ANNALS OF THORACIC SURGERY (2022)

Review Medicine, General & Internal

A Novel Strategy for the Diagnosis of Pulmonary High-Grade Neuroendocrine Tumor

Kentaro Miura, Kimihiro Shimizu, Shogo Ide, Shuji Mishima, Shunichiro Matsuoka, Tetsu Takeda, Takashi Eguchi, Kazutoshi Hamanaka, Takeshi Uehara

Summary: Accurately diagnosing the histologic type of lung cancer is crucial for determining the appropriate treatment. Immunostaining is commonly used for diagnosing high-grade neuroendocrine tumors, with Stathmin-1 immunostaining proving to be a useful tool in this process.

DIAGNOSTICS (2021)

Review Health Care Sciences & Services

Adoption of Robotic Core Technology in Minimally Invasive Lung Segmentectomy: Review

Takashi Eguchi, Kentaro Miura, Kazutoshi Hamanaka, Kimihiro Shimizu

Summary: This article discusses the key issues related to robotic lung segmentectomy, with a focus on the technical features under difficult conditions. It also introduces our preferred surgical strategy and specific maneuvers for robotic lung segmentectomy.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Review Health Care Sciences & Services

Port Placement Variations for Robotic Lung Resection: Focusing on Their History, Conventional Look-Up-View and Horizontal Open-Thoracotomy-View Techniques, and More

Noriaki Sakakura, Takashi Eguchi

Summary: This narrative review summarizes the variations in approaches and port placements used for robotic lung resections. The four-arm, look-up-view method is considered the mainstream approach worldwide. Several variations have been devised, including horizontal open-thoracotomy-view techniques and fewer port and incision techniques. Familiarity with these variations allows thoracic surgeons to choose the optimal procedure for each patient.

JOURNAL OF PERSONALIZED MEDICINE (2023)

Editorial Material Health Care Sciences & Services

Personalized Medicine in Thoracic Surgery: The Role and Future of Robotic-Assisted Techniques

Takashi Eguchi

JOURNAL OF PERSONALIZED MEDICINE (2023)

Review Oncology

Harnessing 3D-CT Simulation and Planning for Enhanced Precision Surgery: A Review of Applications and Advancements in Lung Cancer Treatment

Kazutoshi Hamanaka, Kentaro Miura, Takashi Eguchi, Kimihiro Shimizu

Summary: With the increasing incidence of early-stage lung cancer and the demand for less invasive surgeries, sublobar resections are becoming more common. Three-dimensional imaging technology and software solutions have been developed for precise lung segmentectomy simulations. In the future, artificial intelligence technology and immersive technology such as extended reality can further enhance anatomical recognition and visualization, facilitating high-quality tailor-made sublobar resections for lung cancer.

CANCERS (2023)

No Data Available